Journal: Journal of Cancer
Article Title: MicroRNA-506-3p inhibits ovarian cancer metastasis by down-regulating the expression of EZH2
doi: 10.7150/jca.66959
Figure Lengend Snippet: MiR-506-3p suppresses OvCa tumor metastasis of an orthotopic mouse model of ovarian cancer. HeyA8 cells were injected intraperitoneally into a nu/nu mouse, and an aggressive HeyA8 clone generated from ascites was developed for subsequent use (HeyA8ip1). The mice were randomly divided into control miRNA+DOPC and miR-506-3p+DOPC groups after intraperitoneal injection of HeyA8ip1 cells. (A) In vivo imaging confirmed that miR-506/DOPC nanoliposomes can inhibit OvCa tumor metastasis. (B) Comparison of the incidence of metastases in various organs. (C) Evaluation of miR-506-3p expression in HeyA8-ip1 tumors from control and miR-506-3p treated mice by miRNA in situ hybridization. EZH2 IHC staining was performed on HeyA8-ip1 tumor samples from control and miR-506-3p treated mice. The expression of EZH2 was calculated as the IHC staining score.
Article Snippet: According to the manufacturer's instructions, the miR-506-3p mimic or miR-ctrl was transfected into the OvCa cells at a final concentration of 20 nM with LipofectamineRNAiMAX (Invitrogen, USA).
Techniques: Injection, Generated, In Vivo Imaging, Expressing, In Situ Hybridization, Immunohistochemistry